Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted.
Roberts
Darren M
DM
Roberts
Jason A
JA
D003620:Dantrolene / Q000627:therapeutic use; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000628:therapy*; D012107:Research Design; D016896:Treatment Outcome
D009125:Muscle Relaxants, Central; D003620:Dantrolene